# Oramed Pharmaceuticals Inc.: Form 8-K, filed Aug 21, 2025

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2025-08-21
- Accepted by EDGAR: Aug 21, 2025, 20:06 ET
- Period: 2025-08-19
- Accession: 0001213900-25-079361
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390025079361/ea0254007-8k_oramed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390025079361/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390025079361/ea0254007-8k_oramed.htm

Filed Aug 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-079361. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.